Palvella Therapeutics, Inc.   Report issue

For profit Phase 3
Founded: Wayne PA United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2019
NCT03920228
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Palvella Therapeutics, Inc.